Autor según el artículo: Yu, Edward; Ruiz-Canela, Miguel; Razquin, Cristina; Guasch-Ferre, Marta; Toledo, Estefania; Wang, Dong D; Papandreou, Christopher; Dennis, Courtney; Clish, Clary; Liang, Liming; Bullo, Monica; Corella, Dolores; Fito, Montserrat; Gutierrez-Bedmar, Mario; Lapetra, Jose; Estruch, Ramon; Ros, Emilio; Cofan, Montserrat; Aros, Fernando; Romaguera, Dora; Serra-Majem, Lluis; Sorli, Jose V; Salas-Salvado, Jordi; Hu, Frank B; Martinez-Gonzalez, Miguel A
Departamento: Bioquímica i Biotecnologia
Autor/es de la URV: Bulló Bonet, Mònica / Salas Salvadó, Jorge
Palabras clave: Population study, type 2 diabetes Observational study Insulin resistance Dietary intervention Cohort study observational study insulin resistance dietary intervention cohort study
Resumen: © 2018 John Wiley & Sons Ltd The associations between arginine-based metabolites and incident type 2 diabetes (T2D) are unknown. We employed a case-cohort design, nested within the PREDIMED trial, to examine six plasma metabolites (arginine, citrulline, ornithine, asymmetric dimethylarginine [ADMA], symmetric dimethylarginine [SDMA] and N-monomethyl-l-arginine [NMMA]) among 892 individuals (251 cases) for associations with incident T2D and insulin resistance. Weighted Cox models with robust variance were used. The 1-year changes in arginine (adjusted hazard ratio [HR] per SD 0.68, 95% confidence interval [CI] 0.49, 0.95; Q4 vs. Q1 0.46, 95% CI 0.21, 1.04; P trend = 0.02) and arginine/ADMA ratio (adjusted HR per SD 0.73, 95% CI 0.51, 1.04; Q4 vs. Q1 0.52, 95% CI 0.22, 1.25; P trend = 0.04) were associated with a lower risk of T2D. Positive changes of citrulline and ornithine, and negative changes in SDMA and arginine/(ornithine + citrulline) were associated with concurrent 1-year changes in homeostatic model assessment of insulin resistance. Individuals in the low-fat-diet group had a higher risk of T2D for 1-year changes in NMMA than individuals in Mediterranean-diet groups (P interaction = 0.02). We conclude that arginine bioavailability is important in T2D pathophysiology.
Áreas temáticas: Saúde coletiva Medicina iii Medicina ii Medicina i Internal medicine Endocrinology, diabetes and metabolism Endocrinology & metabolism Endocrinology Educação física Ciências biológicas ii Ciências biológicas i Biotecnología
Acceso a la licencia de uso: https://creativecommons.org/licenses/by/3.0/es/
ISSN: 14628902
Direcció de correo del autor: monica.bullo@urv.cat jordi.salas@urv.cat
Identificador del autor: 0000-0002-0218-7046 0000-0003-2700-7459
Fecha de alta del registro: 2024-10-12
Versión del articulo depositado: info:eu-repo/semantics/acceptedVersion
Enlace a la fuente original: https://dom-pubs.pericles-prod.literatumonline.com/doi/epdf/10.1111/dom.13514
URL Documento de licencia: https://repositori.urv.cat/ca/proteccio-de-dades/
Referencia al articulo segun fuente origial: Diabetes Obesity & Metabolism. 21 (2): 397-401
Referencia de l'ítem segons les normes APA: Yu, Edward; Ruiz-Canela, Miguel; Razquin, Cristina; Guasch-Ferre, Marta; Toledo, Estefania; Wang, Dong D; Papandreou, Christopher; Dennis, Courtney; C (2019). Changes in arginine are inversely associated with type 2 diabetes: A case-cohort study in the PREDIMED trial. Diabetes Obesity & Metabolism, 21(2), 397-401. DOI: 10.1111/dom.13514
DOI del artículo: 10.1111/dom.13514
Entidad: Universitat Rovira i Virgili
Año de publicación de la revista: 2019
Tipo de publicación: Journal Publications